InterCure Ltd
NASDAQ:INCR
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.91
1.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IL |
I
|
InterCure Ltd
TASE:INCR
|
138.1m ILS |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
975.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
549.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219.1B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
267.7B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
94.3B EUR |
Loading...
|
Market Distribution
| Min | -84 760% |
| 30th Percentile | -5.8% |
| Median | 4% |
| 70th Percentile | 10.9% |
| Max | 23 869.1% |
Other Profitability Ratios
InterCure Ltd
Glance View
InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for InterCure Ltd is 8.9%, which is below its 3-year median of 11.8%.
Over the last 3 years, InterCure Ltd’s Operating Margin has increased from -61.5% to 8.9%. During this period, it reached a low of -61.5% on Dec 31, 2020 and a high of 18.5% on Jun 30, 2021.